feed,title,long_url,short_url
Benzinga,"BioMarin Presents ~20% Upside Amid Voxzogo's Success and Slow Roctavian Uptake, Analyst Says",https://benzinga.com/general/biotech/23/07/33118893/biomarin-presents-20-upside-amid-voxzogos-success-and-slow-roctavian-uptake-analyst-says,https://da.gd/u6G62
